Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00603707 · ClinicalTrials.gov registry record

Assessment of Whole Gut Transit Time Using the SmartPill Capsule

A clinical trial, sponsored by The SmartPill Corporation.

Completed
Registry status
178
Enrollment target

NCT00603707: Completed study, sponsored by The SmartPill Corporation.

NCT00603707 is a clinical trial that has completed, run by The SmartPill Corporation. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00603707 has completed, sponsored by The SmartPill Corporation.

COMPLETED
Registry status
178 participants
Enrollment target

Study Summary

Our null hypothesis states that the two techniques (Sitzmarks radioopaque markers and SmartPill) are equivalent and is demonstrated if the study population shows a correlation of 0.7 or higher.

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2006-10
Est. Completion 2008-06
The SmartPill Corporation

3 total trials

What the finished NCT00603707 record still lists

NCT00603707 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00603707 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00603707 about?

NCT00603707 is a clinical study titled "Assessment of Whole Gut Transit Time Using the SmartPill Capsule". Our null hypothesis states that the two techniques (Sitzmarks radioopaque markers and SmartPill) are equivalent and is demonstrated if the study population shows a correlation of 0.7 or higher.

What is the current status of trial NCT00603707?

This trial is currently completed. The enrollment target is 178 participants. The study started on 2006-10. Estimated completion is 2008-06.

Who is sponsoring clinical trial NCT00603707?

This trial is sponsored by The SmartPill Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00603707, the US trial registry maintained by the National Library of Medicine. NCT00603707 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.